 |
0 Diseases |  |
1 Trial |
|
1 Trial |  |
1 News |  |
- | LND101001 / Lupin
New P2 trial, Monotherapy: A study to see how effective and safe two doses of the study drug, LND101001 are compared to a placebo when given to patients with Mild to Moderate Alzheimer (EUDRACT) - Sep 18, 2013
P2, N=171, Ongoing, Sponsor: Lupin Atlantis Holdings S.A.